- Year: 2023
- Scope: 10 Years
- Region: Global
- Pages: 576
- Type: MedSuite
- Description
- Table of Contents
- Companies Included
- Chart List
- Figure List
- Methodology
Product Description
Overall, the global cosmetic surgery and medical aesthetics market was valued at approximately $16.5 billion in 2022. This is expected to increase over the forecast period at a CAGR of 6.3% to exceed $25.2 billion.
The full report suite on the global market for cosmetic surgery and medical aesthetics includes botulinum toxin A, dermal filler, breast implant, facial and body implant, liposuction device, minimally invasive fat reduction device and aesthetic laser and light therapy segments.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL COSMETIC SURGERY AND MEDICAL AESTHETICS MARKET INSIGHTS
The total market will be driven by social media and changing societal beauty standards. Social media has reshaped the definition of beauty and, even more significantly, the ability to reach a wider audience. In addition to creating unrealistic standards of beauty, social media also allows patients to share before and after photos, along with access to pages to look into the corresponding treatments. As social influencers continue to share their experiences through social media platforms, the patient population of the aesthetic market will explode, which is particularly true of the younger demographic.
GLOBAL COSMETIC SURGERY AND MEDICAL AESTHETICS MARKET SHARE INSIGHTS
The global cosmetic surgery and medical aesthetics market was dominated by AbbVie, Galderma, Merz Aesthetics and Johnson & Johnson. Collectively, these companies accounted for over half of the overall market value.
AbbVie won over the leading position in the market by having the largest foothold in the botulinum toxin A, dermal filler and minimally invasive fat reduction segments. The company achieved this wide portfolio through strategic acquisitions. In May 2020, AbbVie completed the acquisition of Allergan and established a global business, Allergan Aesthetics. Back in 2017, Allergan has acquired Zeltiq Aesthetics, adding CoolSculpting® to its product list.
MARKET SEGMENTATION SUMMARY
All of the below segments are included within the Global report, however, each can be purchased individually as MedCore’s:
-
Global Botulinum Toxin A Market | MedCore – Includes:
- Aesthetic and therapeutic segments.
-
Global Dermal Filler Market | MedCore – Includes:
- Hyaluronic acid (HA) and synthetic dermal filler markets.
-
Global Breast Implant Market | MedCore – Segmented by:
- Procedure: breast augmentation, breast implant removal, breast lift, breast reduction
- Material: saline and silicone (smooth, textured)
- Shape: round, anatomical
-
Global Facial and Body Implant Market | MedCore – Segmented by:
- Procedure: facial and body implant (chin, malar, pectoral, gluteal, calf)
- Device: chin, malar, pectoral, gluteal, calf
-
Global Liposuction Device Market | MedCore – Segmented by:
- Device: tubing, cannula, aspiration unit
-
Global Minimally Invasive Fat Reduction Device Market | MedCore – Segmented by:
- Approach: Kybella®, non-injectable fat reduction
-
Global Aesthetic Laser and Light Therapy Market | MedCore – Segmented by:
- Approach: skin tightening, laser skin resurfacing, microdermabrasion, intense pulsed light (IPL), and laser hair removal
- Device: intense pulsed light system, fractional laser, RF skin tightening, diode laser, and tattoo removal device
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions |
North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast Period | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data. Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavor never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
FREE Sample Report
Table of Contents
| TABLE of CONTENTS |
| List of Figures |
| List of Charts |
| executive summary |
| Global Cosmetic Surgery and Medical Aesthetics Market Overview |
| Competitive Analysis |
| Market Trends |
| Market Developments |
| Procedures Included |
| Markets Included |
| Regions Included |
| Version History |
| research methodology |
| Step 1: Project Initiation & Team Selection |
| Step 2: Prepare Data Systems and Perform Secondary Research |
| Step 3: Preparation for Interviews & Questionnaire Design |
| Step 4: Performing Primary Research |
| Step 5: Research Analysis: Establishing Baseline Estimates |
| Step 6: Market Forecast and Analysis |
| Step 7: Identify Strategic Opportunities |
| Step 8: Final Review and Market Release |
| Step 9: Customer Feedback and Market Monitoring |
| impact of covid-19 on THE global Cosmetic Surgery and Medical Aesthetic Market |
| 2.1 Introduction |
| 2.2 Regional Profiles |
| 2.3 Analysis By Market Segment |
| 2.3.1 Worst Case Scenario |
| 2.3.2 Base Case Scenario |
| 2.3.3 Best Case Scenario |
| Disease Overview |
| 3.1 Patient Demographics |
| 3.1.1 Obesity |
| 3.1.2 Therapeutic Application of Botulinum Toxin |
| 3.1.3 Breast Reconstruction |
| 3.1.4 Augmentation Procedures |
| Product Assessment |
| 4.1 Introduction |
| 4.2 Product Portfolios |
| 4.2.1 Botulinum Toxin A |
| 4.2.2 Dermal Filler |
| 4.2.3 Breast Implant |
| 4.2.4 Facial and Body Implant |
| 4.2.5 Liposuction Device |
| 4.2.6 Minimally Invasive Fat Reduction |
| 4.2.7 Aesthetic Laser and Light Therapy |
| 4.3 Regulatory Issues and Recalls |
| 4.3.1 Dermal Filler |
| 4.3.1.1 Prollenium Medical Technologies |
| 4.3.2 Breast Implant |
| 4.3.2.1 AbbVie |
| 4.3.2.2 Allergan |
| 4.3.2.3 Johnson & Johnson |
| 4.3.2.4 Ideal Implant |
| 4.3.3 Liposuction Device |
| 4.3.3.1 LipoSales |
| 4.3.4 Minimally Invasive Fat Reduction |
| 4.3.4.1 AbbVie |
| 4.3.5 Aesthetic Laser and Light Therapy |
| 4.3.5.1 Bausch Health |
| 4.3.5.2 Dornier |
| 4.4 Clinical Trials |
| 4.4.1 Botulinum toxin |
| 4.4.2 Dermal Filler |
| 4.4.3 Breast Implant |
| 4.4.4 Facial and Body Implant |
| 4.4.5 Liposuction Device |
| 4.4.6 Minimally Invasive Fat Reduction |
| 4.4.7 Aesthetic Laser and Light Therapy |
| Global Cosmetic Surgery and Medical Aesthetic Market Overview |
| 5.1 Introduction |
| 5.2 Procedure Data Overview |
| 5.2.1 By Segment |
| 5.2.1.1 Surgical Procedures |
| 5.2.1.1.1 Augmentation Procedures by Segment |
| 5.2.1.1.2 Augmentation Procedures by Region |
| 5.2.1.1.3 Augmentation Procedures by Country |
| 5.2.1.2 Minimally Invasive Procedures |
| 5.2.2 By Region |
| 5.3 Market Overview & Trend Analysis |
| 5.3.1 By Segment |
| 5.3.2 By Region |
| 5.4 Drivers and Limiters |
| 5.4.1 Market Drivers |
| 5.4.2 Market Limiters |
| 5.5 Competitive Market Share Analysis |
| 5.6 Mergers and Acquisitions |
| 5.7 Company Profiles |
| 5.7.1 AbbVie |
| 5.7.2 Bausch Health |
| 5.7.3 Candela |
| 5.7.4 Clayton, Dubilier & Rice |
| 5.7.5 Cutera |
| 5.7.6 Galderma |
| 5.7.7 Implantech |
| 5.7.8 Johnson & Johnson |
| 5.7.9 Lumenis |
| 5.7.10 Merz Aesthetics |
| 5.7.11 Sciton |
| 5.7.12 Wells Johnson |
| 5.8 SWOT Analysis |
| 5.8.1 AbbVie |
| 5.8.2 Bausch Health |
| 5.8.3 Candela |
| 5.8.4 Clayton, Dubilier & Rice |
| 5.8.5 Cutera |
| 5.8.6 Galderma |
| 5.8.7 Implantech |
| 5.8.8 Johnson & Johnson |
| 5.8.9 Lumenis |
| 5.8.10 Merz Aesthetics |
| 5.8.11 Sciton |
| 5.8.12 Wells Johnson |
| Botulinum Toxin A Market |
| 6.1 Executive Summary |
| 6.1.1 Global Botulinum Toxin A Market Overview |
| 6.1.2 Competitive Analysis |
| 6.1.3 Markets Included |
| 6.1.4 Regions Included |
| 6.2 Introduction |
| 6.3 Procedure Numbers |
| 6.4 Market Overview |
| 6.4.1 By Segment |
| 6.4.2 By Region |
| 6.5 Market Analysis and Forecast |
| 6.5.1 Total Botulinum Toxin A Market |
| 6.5.2 Aesthetic Botulinum Toxin A Market |
| 6.5.3 Therapeutic Botulinum Toxin A Market |
| 6.6 Drivers and Limiters |
| 6.6.1 Market Drivers |
| 6.6.2 Market Limiters |
| 6.7 Competitive Market Share Analysis |
| Dermal Filler Market |
| 7.1 Executive Summary |
| 7.1.1 Global Dermal Filler Market Overview |
| 7.1.2 Competitive Analysis |
| 7.1.3 Procedures Included |
| 7.1.4 Markets Included |
| 7.1.5 Regions Included |
| 7.2 Introduction |
| 7.3 Procedure Numbers |
| 7.3.1 Total Dermal Filler Procedures |
| 7.3.2 Hyaluronic Acid Dermal Filler Procedures |
| 7.3.3 Synthetic Dermal Filler Procedures |
| 7.4 Market Overview |
| 7.4.1 By Segment |
| 7.4.2 By Region |
| 7.5 Market Analysis and Forecast |
| 7.5.1 Total Dermal Filler Market |
| 7.5.2 Hyaluronic Acid Dermal Filler Market |
| 7.5.3 Synthetic Dermal Filler Market |
| 7.6 Drivers and Limiters |
| 7.6.1 Market Drivers |
| 7.6.2 Market Limiters |
| 7.7 Competitive Market Share Analysis |
| breast implant Market |
| 8.1 Executive Summary |
| 8.1.1 Global Breast Implant Market Overview |
| 8.1.2 Competitive Analysis |
| 8.1.3 Procedures Included |
| 8.1.4 Markets Included |
| 8.1.5 Regions Included |
| 8.2 Introduction |
| 8.3 Procedure Numbers |
| 8.3.1 Total Breast Procedures |
| 8.3.2 Breast Augmentation Procedures |
| 8.3.3 Breast Implant Removal Procedures |
| 8.3.4 Breast Lift Procedures |
| 8.3.5 Breast Reduction Procedures |
| 8.4 Market Overview |
| 8.4.1 By Segment |
| 8.4.2 By Region |
| 8.5 Market Analysis and Forecast |
| 8.5.1 Total Breast Implant Market |
| 8.5.2 Breast Implant Market by Product Type |
| 8.5.2.1 Saline Breast Implant Market |
| 8.5.2.2 Silicone Breast Implant Market |
| 8.5.2.3 Silicone Breast Implant Market by Segment |
| 8.5.2.3.1 Smooth Silicone Breast Implant Market |
| 8.5.2.3.2 Textured Silicone Breast Implant Market |
| 8.5.3 Unit Analysis by Implant Shape |
| 8.6 Drivers and Limiters |
| 8.6.1 Market Drivers |
| 8.6.2 Market Limiters |
| 8.7 Competitive Market Share Analysis |
| Facial and body implant Market |
| 9.1 Executive Summary |
| 9.1.1 Global Facial and Body Implant Market Overview |
| 9.1.2 Competitive Analysis |
| 9.1.3 Procedures Included |
| 9.1.4 Markets Included |
| 9.1.5 Regions Included |
| 9.2 Introduction |
| 9.3 Procedure Numbers |
| 9.3.1 Total Facial and Body Implant Procedures |
| 9.3.2 Chin Implant Procedures |
| 9.3.3 Malar Implant Procedures |
| 9.3.4 Pectoral Implant Procedures |
| 9.3.5 Gluteal Implant Procedures |
| 9.3.6 Calf Implant Procedures |
| 9.4 Market Overview |
| 9.4.1 By Segment |
| 9.4.2 By Region |
| 9.5 Market Analysis and Forecast |
| 9.5.1 Total Facial and Body Implant Market |
| 9.5.2 Chin Implant Market |
| 9.5.3 Malar Implant Market |
| 9.5.4 Pectoral Implant Market |
| 9.5.5 Gluteal Implant Market |
| 9.5.6 Calf Implant Market |
| 9.6 Drivers and Limiters |
| 9.6.1 Market Drivers |
| 9.6.2 Market Limiters |
| 9.7 Competitive Market Share Analysis |
| Liposuction Device Market |
| 10.1 Executive Summary |
| 10.1.1 Global Liposuction Device Market Overview |
| 10.1.2 Competitive Analysis |
| 10.1.3 Markets Included |
| 10.1.4 Regions Included |
| 10.2 Introduction |
| 10.3 Procedure Numbers |
| 10.4 Market Overview |
| 10.4.1 By Segment |
| 10.4.2 By Region |
| 10.5 Market Analysis and Forecast |
| 10.5.1 Liposuction Tubing Market |
| 10.5.2 Liposuction Cannula Market |
| 10.5.3 Liposuction Aspiration Unit Market |
| 10.6 Drivers and Limiters |
| 10.6.1 Market Drivers |
| 10.6.2 Market Limiters |
| 10.7 Competitive Market Share Analysis |
| Minimally Invasive Fat Reduction Device Market |
| 11.1 Executive Summary |
| 11.1.1 Global Minimally Invasive Fat Reduction Device Market Overview |
| 11.1.2 Competitive Analysis |
| 11.1.3 Procedures Included |
| 11.1.4 Markets Included |
| 11.1.5 Regions Included |
| 11.2 Introduction |
| 11.3 Procedure Numbers |
| 11.3.1 Total Minimally Invasive Fat Reduction Procedures |
| 11.3.2 Kybella® Injection Procedures |
| 11.3.3 Non-Injectable Fat Reduction Procedures |
| 11.4 Market Overview |
| 11.4.1 By Segment |
| 11.4.2 By Region |
| 11.5 Market Analysis and Forecast |
| 11.5.1 Cryolipolysis Device Market |
| 11.5.2 Ultrasound Lipolysis Device Market |
| 11.5.3 Laser Lipolysis Device Market |
| 11.5.4 Kybella® Injection Market |
| 11.6 Drivers and Limiters |
| 11.6.1 Market Drivers |
| 11.6.2 Market Limiters |
| 11.7 Competitive Market Share Analysis |
| Aesthetic Laser and Light Therapy Market |
| 12.1 Executive Summary |
| 12.1.1 Global Aesthetic Laser and Light Therapy Market Overview |
| 12.1.2 Competitive Analysis |
| 12.1.3 Procedures Included |
| 12.1.4 Markets Included |
| 12.1.5 Regions Included |
| 12.2 Introduction |
| 12.3 Procedure Numbers |
| 12.3.1 Total Laser and Light Procedures |
| 12.3.2 Skin Tightening Procedures |
| 12.3.3 Laser Skin Resurfacing Procedures |
| 12.3.4 Microdermabrasion Procedures |
| 12.3.5 Intense Pulsed Light Procedures |
| 12.3.6 Laser Hair Removal Procedures |
| 12.4 Market Overview |
| 12.4.1 By Segment |
| 12.4.2 By Region |
| 12.5 Market Analysis and Forecast |
| 12.5.1 Total Aesthetic Laser and Light Therapy Market |
| 12.5.2 Intense Pulsed Light System Market |
| 12.5.3 Fractional Laser Market |
| 12.5.4 RF Skin Tightening Market |
| 12.5.5 Diode Laser Market |
| 12.5.6 Tattoo Removal Device Market |
| 12.6 Drivers and Limiters |
| 12.6.1 Market Drivers |
| 12.6.2 Market Limiters |
| 12.7 Competitive Market Share Analysis |
| Abbreviations |
Companies Included:
| · AbbVie | · Hans Biomed |
| · Allied Biomedical | · Hanson Medical |
| · Alpha Aesthetics | · Henry Schein |
| · Anthony Products | · Huadong Medicine |
| · Arion Laboratories | · Hugel |
| · Astanza Lasers | · Huons Global |
| · Bausch Health | · Hydrafacial |
| · BR Surgical | · Ideal Implant |
| · BTL Aesthetics | · i-Lipo |
| · Candela | · Implantech |
| · Cartessa | · InMode |
| · Cereplas | · Innovative Med |
| · Clayton, Dubilier & Rice | · Invotec |
| · Croma-Pharma | · Johnson & Johnson |
| · Cutera | · JT Medical |
| · Cytophil | · JULLSURG |
| · Deka Medical | · Lanzhou Institute of Biological Products |
| · DermaMed Solutions | · LipoSales |
| · El.En Spa | · Lumenis |
| · Erchonia | · Lynton Lasers |
| · Establishment Labs | · Marina Medical |
| · Eurosurgical | · Matrix Surgical |
| · Evolus | · MedCo |
| · Fillmed | · Medline |
| · Fosun Pharma | · Medytox |
| · Fotona | · Merz Aesthetics |
| · Galderma | · MicroAire |
| · GC Aesthetics | · Photo Biotech |
| · Genesis Biosystems | · Polytech |
| · Guangzhou Wanhe Plastic Materials | · Prollenium Medical Technologies |
| · Revance | · Surgiform |
| · Rohrer Aesthetics | · SurgiMedics |
| · Sciton | · Sybaritic |
| · Sebbin | · Teoxane |
| · Shanghai Kangning Medical Device | · Venus |
| · Shippert Medical Technologies | · Viora Med |
| · Sientra | · Wanhe |
| · Sisram Medical | · Wells Johnson |
| · Strawberry Laser | · YOLO Medical |
| · Suneva Medical | · Zimmer MedizinSysteme |
List of Charts
| Chart 1‑1: Cosmetic Surgery and Medical Aesthetic Market by Segment, Global, 2022 – 2029 |
| Chart 1‑2: Global Cosmetic Surgery and Medical Aesthetic Procedures, Global, 2022 |
| Chart 2‑1: Multi-Scenario Cosmetic Surgery and Medical Aesthetic Market Forecast, Global, 2019 – 2029 (US$M) |
| Chart 5‑1: Cosmetic Surgery and Medical Aesthetic Procedures by Segment, Global, 2019 – 2029 |
| Chart 5‑2: Cosmetic Surgery and Medical Aesthetic Procedures by Region, Global, 2019 – 2029 |
| Chart 5‑3: Cosmetic Surgery and Medical Aesthetic Market by Segment, Global, 2019 – 2029 |
| Chart 5‑4: Cosmetic Surgery and Medical Aesthetic Market by Region, Global, 2019 – 2029 |
| Chart 5‑5: Leading Competitors, Cosmetic Surgery and Medical Aesthetic Market, Global, 2022 |
| Chart 6‑1: Botulinum Toxin A Market, Global, 2022 & 2029 |
| Chart 6‑2: Botulinum Toxin A Procedures, Global, 2022 |
| Chart 6‑3: Botulinum Toxin A Procedures by Region, Global, 2019 – 2029 |
| Chart 6‑4: Botulinum Toxin A Market by Segment, Global, 2019 – 2029 |
| Chart 6‑5: Botulinum Toxin A Market by Region, Global, 2019 – 2029 |
| Chart 6‑6: Leading Competitors, Botulinum Toxin A Market, Global, 2022 |
| Chart 7‑1: Dermal Filler Market, Global, 2022 & 2029 |
| Chart 7‑2: Dermal Filler Procedures, Global, 2022 |
| Chart 7‑3: Dermal Filler Procedures by Segment, Global, 2019 – 2029 |
| Chart 7‑4: Dermal Filler Procedures by Region, Global, 2019 – 2029 |
| Chart 7‑5: Dermal Filler Market by Segment, Global, 2019 – 2029 |
| Chart 7‑6: Dermal Filler Market by Region, Global, 2019 – 2029 |
| Chart 7‑7: Leading Competitors, Dermal Filler Market, Global, 2022 |
| Chart 8‑1: Breast Implant Market, Global, 2022 & 2029 |
| Chart 8‑2: Breast Procedures, Global, 2022 |
| Chart 8‑3: Breast Procedures by Segment, Global, 2019 – 2029 |
| Chart 8‑4: Breast Procedures by Region, Global, 2019 – 2029 |
| Chart 8‑5: Breast Implant Market by Segment, Global, 2019 – 2029 |
| Chart 8‑6: Breast Implant Market by Region, Global, 2019 – 2029 |
| Chart 8‑7: Leading Competitors, Breast Implant Market, Global, 2022 |
| Chart 9‑1: Facial and Body Implant Market, Global, 2022 & 2029 |
| Chart 9‑2: Facial and Body Implant Procedures, Global, 2022 |
| Chart 9‑3: Facial and Body Implant Procedures by Segment, Global, 2019 – 2029 |
| Chart 9‑4: Facial and Body Implant Procedures by Region, Global, 2019 – 2029 |
| Chart 9‑5: Facial and Body Implant Market by Segment, Global, 2019 – 2029 |
| Chart 9‑6: Facial and Body Implant Market by Region, Global, 2019 – 2029 |
| Chart 9‑7: Leading Competitors, Facial and Body Implant Market, Global, 2022 |
| Chart 10‑1: Liposuction Device Market, Global, 2022 & 2029 |
| Chart 10‑2: Liposuction Procedures, Global, 2022 |
| Chart 10‑3: Liposuction Procedures by Region, Global, 2019 – 2029 |
| Chart 10‑4: Liposuction Device Market by Segment, Global, 2019 – 2029 |
| Chart 10‑5: Liposuction Device Market by Region, Global, 2019 – 2029 |
| Chart 10‑6: Leading Competitors, Liposuction Device Market, Global, 2022 |
| Chart 11‑1: Minimally Invasive Fat Reduction Device Market, Global, 2022 & 2029 |
| Chart 11‑2: Minimally Invasive Fat Reduction Procedures, Global, 2022 |
| Chart 11‑3: Minimally Invasive Fat Reduction Procedures by Segment, Global, 2019 – 2029 |
| Chart 11‑4: Minimally Invasive Fat Reduction Procedures by Region, Global, 2019 – 2029 |
| Chart 11‑5: Minimally Invasive Fat Reduction Device Market by Segment, Global, 2019 – 2029 |
| Chart 11‑6: Minimally Invasive Fat Reduction Device Market by Region, Global, 2019 – 2029 |
| Chart 11‑7: Leading Competitors, Minimally Invasive Fat Reduction Device Market, Global, 2022 |
| Chart 12‑1: Aesthetic Laser and Light Therapy Market, Global, 2022 & 2029 |
| Chart 12‑2: Aesthetic Laser and Light Therapy Procedures, Global, 2022 |
| Chart 12‑3: Aesthetic Laser and Light Procedures by Segment, Global, 2019 – 2029 |
| Chart 12‑4: Aesthetic Laser and Light Procedures by Region, Global, 2019 – 2029 |
| Chart 12‑5: Aesthetic Laser and Light Therapy Market by Segment, Global, 2019 – 2029 |
| Chart 12‑6: Aesthetic Laser and Light Therapy Market by Region, Global, 2019 – 2029 |
| Chart 12‑7: Leading Competitors, Aesthetic Laser and Light Therapy Market, Global, 2022 |
List of Figures
| Figure 1‑1: Cosmetic Surgery and Medical Aesthetic Market Share Ranking by Segment, Global, 2022 (1 of 2) |
| Figure 1‑2: Cosmetic Surgery and Medical Aesthetic Market Share Ranking by Segment, Global, 2022 (2 of 2) |
| Figure 1‑3: Companies Researched in This Report (1 of 2) |
| Figure 1‑4: Companies Researched in This Report (2 of 2) |
| Figure 1‑5: Factors Impacting the Cosmetic Surgery and Medical Aesthetic Market by Segment, Global (1 of 2) |
| Figure 1‑6: Factors Impacting the Cosmetic Surgery and Medical Aesthetic Market by Segment, Global (2 of 2) |
| Figure 1‑7: Recent Events in the Cosmetic Surgery and Medical Aesthetic Market, Global, 2019 – 2023 (1 of 5) |
| Figure 1‑8: Recent Events in the Cosmetic Surgery and Medical Aesthetic Market, Global, 2019 – 2023 (2 of 5) |
| Figure 1‑9: Recent Events in the Cosmetic Surgery and Medical Aesthetic Market, Global, 2019 – 2023 (3 of 5) |
| Figure 1‑10: Recent Events in the Cosmetic Surgery and Medical Aesthetic Market, Global, 2019 – 2023 (4 of 5) |
| Figure 1‑11: Recent Events in the Cosmetic Surgery and Medical Aesthetic Market, Global, 2019 – 2023 (5 of 5) |
| Figure 1‑12: Cosmetic Surgery and Medical Aesthetic Market Procedures Covered (1 of 2) |
| Figure 1‑13: Cosmetic Surgery and Medical Aesthetic Market Procedures Covered (2 of 2) |
| Figure 1‑14: Cosmetic Surgery and Medical Aesthetic Markets Covered |
| Figure 1‑15: Cosmetic Surgery and Medical Aesthetic Market Regions Covered, Global (1 of 2) |
| Figure 1‑16: Cosmetic Surgery and Medical Aesthetic Market Regions Covered, Global (2 of 2) |
| Figure 1‑17: Version History |
| Figure 2‑1: Cosmetic Surgery and Medical Aesthetic Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) |
| Figure 2‑2: Cosmetic Surgery and Medical Aesthetic Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) |
| Figure 2‑3: Cosmetic Surgery and Medical Aesthetic Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) |
| Figure 4‑1: Botulinum Toxin A Products by Company |
| Figure 4‑2: Dermal Filler Products by Company |
| Figure 4‑3: Breast Implant by Company |
| Figure 4‑4: Facial and Body Implant by Company |
| Figure 4‑5: Liposuction Device by Company |
| Figure 4‑6: Minimally Invasive Fat Reduction Device by Company |
| Figure 4‑7: Aesthetic Laser and Light Therapy Device by Company (1 of 2) |
| Figure 4‑8: Aesthetic Laser and Light Therapy Device by Company (2 of 2) |
| Figure 4‑9: Class 2 Device Recall Revanesse Versa |
| Figure 4‑10: Class 3 Device Recall NATRELLE Silicone Filled Breast Implants |
| Figure 4‑11: Class 3 Device Recall NATRELLE INSPIRA SiliconeFilled Breast Implants |
| Figure 4‑12: Class 3 Device Recall NATRELLE SalineFilled Breast Implants |
| Figure 4‑13: Class 1 Device Recall Natrelle 410, Highly Cohesive Anatomically Shaped SiliconeFilled Breast Implant |
| Figure 4‑14: Class 1 Device Recall NATRELLE 150 Breast Implants |
| Figure 4‑15: Class 1 Device Recall Natrelle Ritz Princess Breast Implants |
| Figure 4‑16: Class 1 Device Recall NATRELLE Komuro Breast Implants |
| Figure 4‑17: Class 1 Device Recall Natrelle and McGhan SiliconeFilled Breast Implants |
| Figure 4‑18: Class 1 Device Recall Natrelle and McGhan 410 Soft Touch Breast Implant |
| Figure 4‑19: Class 1 Device Recall McGhan BioDIMENSIONAL SiliconeFilled Breast Implants |
| Figure 4‑20: Class 1 Device Recall Natrelle SiliconeFilled Breast Implant |
| Figure 4‑21: Class 1 Device Recall Natrelle Inspira, SiliconeFilled Breast Implants |
| Figure 4‑22: Class 1 Device Recall Natrelle SalineFilled Breast Implant |
| Figure 4‑23: Class 2 Device Recall Smooth Round Saline Diaphragm Valve (DV) Breast Implants |
| Figure 4‑24: Class 2 Device Recall IDEAL IMPLANT Structured Breast Implant |
| Figure 4‑25: Class 2 Device Recall AXS Universal Aspiration Tubing |
| Figure 4‑26: Class 2 Device Recall CoolSculpting Elite System |
| Figure 4‑27: Class 2 Device Recall THERMAGE CPT SYSTEM |
| Figure 4‑28: Class 2 Device Recall Dornier |
| Figure 4‑29: Investigating Temporalis and Masseter Botox Injection Before Orthognathic Surgery to Improve Postoperative Pain |
| Figure 4‑30: BOTOX® vs. XEOMIN® for Chronic Migraine |
| Figure 4‑31: The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower Extremities |
| Figure 4‑32: Muscle Weakness Duration After Single Botulinum Toxin Injection in Masseter |
| Figure 4‑33: Botulinum Toxin in the Treatment of Gingival Smile |
| Figure 4‑34: Functional Effects of Botox on the Brain Using MRS and fMRI |
| Figure 4‑35: Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence |
| Figure 4‑36: Safety and Performance of DKL Crosslinked Sodium Hyaluronate 26 Dermal Filler for Cheek Augmentation |
| Figure 4‑37: Safety and Efficacy of the HA-based Dermal Fillers HYAcorp Lips and Face (PMCF_HYAcorp) |
| Figure 4‑38: Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina |
| Figure 4‑39: Evaluation of Collagen Dermal Filler With Lidocaine for the Correction of Nasolabial Folds |
| Figure 4‑40: Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face (RaLido) |
| Figure 4‑41: An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants (STEPS A) |
| Figure 4‑42: Molecular Mechanisms Associated With Breast Implant Complications (MMABIC) |
| Figure 4‑43: Understanding the Phenomena of Aging and Rupture of Breast Implants (CRIMA) |
| Figure 4‑44: Effect of Breast Implants om Mammography Screening |
| Figure 4‑45: Standard Silicone-Based vs. B-Lite® Light Weight Breast Implant After Total Mastectomy and Radiotherapy for Breast Cancer |
| Figure 4‑46: Core Study of the Safety and Effectiveness of IDEAL IMPLANT(R) Saline-Filled Breast Implants |
| Figure 4‑47: SEBBIN Round, Anatomical and Biconvex Gluteal Implants |
| Figure 4‑48: Patient-Specific Alloplastic Chin Implant Versus Computer Guided Genioplasty: Soft Tissue Assessment After One Year Follow up |
| Figure 4‑49: The Degree of Accuracy of Patient-Specific PEEK Implant to Restore Chin Deficiency |
| Figure 4‑50: The National Lipedema Study |
| Figure 4‑51: RF and PEMF Following Liposuction |
| Figure 4‑52: Treatment of Mild and Moderate Cases of Gynaecomastia |
| Figure 4‑53: The Effect of Liposuction on Menses: A Retrospective Study |
| Figure 4‑54: Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System |
| Figure 4‑55: A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction |
| Figure 4‑56: Evaluation of the Safety and Efficacy of REBORN System for Lipolysis Treatment |
| Figure 4‑57: Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat |
| Figure 4‑58: Coolsculpting With Cooltone Versus Coolsculpting Alone for the Banana Roll Area |
| Figure 4‑59: Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen |
| Figure 4‑60: CoolSculpting® Elite for Non-Invasive Fat Reduction |
| Figure 4‑61: Kybella for the Treatment of Flank Fat (FF) |
| Figure 4‑62: Evaluation of the Safety and Efficacy of the NuEra Tight for Abdominal Circumference Reduction |
| Figure 4‑63: Safety and Efficacy of Deoxycholic Acid Injection for Reduction of Upper Inner Thigh Fat |
| Figure 4‑64: Cryolipolysis for Jawline Contouring (JAW) |
| Figure 4‑65: Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color |
| Figure 4‑66: Clinical Evaluation to Demonstrate the Safety and Performance of the Candela PicoWay System™ |
| Figure 4‑67: Assessment Skin Quality and Efficacy of Dermal Line After Four Bipolar Radiofrequency Microneedling Treatments |
| Figure 4‑68: Pilot Study of Multi-wavelength Laser for Tattoo Removal |
| Figure 4‑69: Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment |
| Figure 4‑70: To Compare the Effectiveness of Two Lasers in the Treatment of Unwanted Hair |
| Figure 4‑71: Coolsculpting With Cooltone Versus Coolsculpting Alone for the Banana Roll Area |
| Figure 4‑72: Sunstone IPL (Intense Pulsed Light) for Hair Reduction |
| Figure 4‑73: Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata |
| Figure 4‑74: Bausch Health Thermage FXL for Use on Lower Face and Submentum Area |
| Figure 4‑75: Non-invasive Improvement of Buttocks With Magnetic Device |
| Figure 4‑76: Performance Evaluation of Tattoo Removal |
| Figure 5‑1: Cosmetic Surgery and Medical Aesthetic Procedures by Segment, Global, 2019 – 2029 |
| Figure 5‑2: Surgical Cosmetic Procedures by Segment, Global, 2019 – 2029 |
| Figure 5‑3: Surgical Augmentation Cosmetic Procedures by Segment, Global, 2019 – 2029 (1 of 2) |
| Figure 5‑4: Surgical Augmentation Cosmetic Procedures by Segment, Global, 2019 – 2029 (2 of 2) |
| Figure 5‑5: Augmentation Procedures by Region, Global, 2019 – 2029 |
| Figure 5‑6: Augmentation Procedures by Country, North America, 2019 – 2029 |
| Figure 5‑7: Augmentation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 5‑8: Augmentation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 5‑9: Augmentation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 5‑10: Augmentation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 5‑11: Augmentation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 5‑12: Augmentation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 5‑13: Augmentation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 5‑14: Augmentation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 5‑15: Augmentation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 5‑16: Augmentation Procedures by Country, Africa, 2019 – 2029 |
| Figure 5‑17: Minimally Invasive Cosmetic Procedures by Segment, Global, 2019 – 2029 |
| Figure 5‑18: Facial Injection Procedures by Segment, Global, 2019 – 2029 |
| Figure 5‑19: Laser and Light Therapy Procedures by Segment, Global, 2019 – 2029 |
| Figure 5‑20: Minimally Invasive Fat Reduction Procedures by Segment, Global, 2019 – 2029 |
| Figure 5‑21: Cosmetic Surgery and Medical Aesthetic Procedures by Region, Global, 2019 – 2029 |
| Figure 5‑22: Cosmetic Surgery and Medical Aesthetic Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 5‑23: Cosmetic Surgery and Medical Aesthetic Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 5‑24: Leading Competitors, Cosmetic Surgery and Medical Aesthetic Market by Segment, Global, 2022 |
| Figure 5‑25: SWOT Analysis, AbbVie (1 of 2) |
| Figure 5‑26: SWOT Analysis, AbbVie (2 of 2) |
| Figure 5‑27: SWOT Analysis, Bausch Health |
| Figure 5‑28: SWOT Analysis, Candela |
| Figure 5‑29: SWOT Analysis, Clayton, Dubilier & Rice |
| Figure 5‑30: SWOT Analysis, Cutera |
| Figure 5‑31: SWOT Analysis, Galderma |
| Figure 5‑32: SWOT Analysis, Implantech |
| Figure 5‑33: SWOT Analysis, Johnson & Johnson |
| Figure 5‑34: SWOT Analysis, Lumenis |
| Figure 5‑35: SWOT Analysis, Merz Aesthetics |
| Figure 5‑36: SWOT Analysis, Sciton |
| Figure 5‑37: SWOT Analysis, Wells Johnson |
| Figure 6‑1: Botulinum Toxin A Markets Covered |
| Figure 6‑2: Botulinum Toxin A Regions Covered, Global (1 of 2) |
| Figure 6‑3: Botulinum Toxin A Regions Covered, Global (2 of 2) |
| Figure 6‑4: Botulinum Toxin A Procedures by Region, Global, 2019 – 2029 |
| Figure 6‑5: Botulinum Toxin A Procedures by Country, North America, 2019 – 2029 |
| Figure 6‑6: Botulinum Toxin A Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 6‑7: Botulinum Toxin A Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 6‑8: Botulinum Toxin A Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 6‑9: Botulinum Toxin A Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 6‑10: Botulinum Toxin A Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 6‑11: Botulinum Toxin A Procedures by Country, Middle East, 2019 – 2029 |
| Figure 6‑12: Botulinum Toxin A Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 6‑13: Botulinum Toxin A Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 6‑14: Botulinum Toxin A Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 6‑15: Botulinum Toxin A Procedures by Country, Africa, 2019 – 2029 |
| Figure 6‑16: Botulinum Toxin A by Segment, Global, 2019 – 2029 (US$M) |
| Figure 6‑17: Botulinum Toxin A Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 6‑18: Botulinum Toxin A Market, Global, 2019 – 2029 |
| Figure 6‑19: Units Sold (100IU) by Region Botulinum Toxin A Market, Global, 2019 – 2029 |
| Figure 6‑20: Average Selling Price by Region, Botulinum Toxin A Market, Global, 2019 – 2029 (US$) |
| Figure 6‑21: Market Value by Region, Botulinum Toxin A Market, Global, 2019 – 2029 (US$M) |
| Figure 6‑22: Aesthetic Botulinum Toxin A Market, Global, 2019 – 2029 |
| Figure 6‑23: Units Sold (100IU) by Region, Aesthetic Botulinum Toxin A Market, Global, 2019 – 2029 |
| Figure 6‑24: Average Selling Price by Region, Aesthetic Botulinum Toxin A Market, Global, 2019 – 2029 (US$) |
| Figure 6‑25: Market Value by Region, Aesthetic Botulinum Toxin A Market, Global, 2019 – 2029 (US$M) |
| Figure 6‑26: Therapeutic Botulinum Toxin A Market, Global, 2019 – 2029 |
| Figure 6‑27: Units Sold (100IU) by Region, Therapeutic Botulinum Toxin A Market, Global, 2019 – 2029 |
| Figure 6‑28: Average Selling Price by Region, Therapeutic Botulinum Toxin A Market, Global, 2019 – 2029 (US$) |
| Figure 6‑29: Market Value by Region, Therapeutic Botulinum Toxin A Market, Global, 2019 – 2029 (US$M) |
| Figure 6‑30: Leading Competitors, Botulinum Toxin A Market, Global, 2022 |
| Figure 7‑1: Dermal Filler Procedures Covered |
| Figure 7‑2: Dermal Filler Markets Covered |
| Figure 7‑3: Dermal Filler Market Regions Covered, Global (1 of 2) |
| Figure 7‑4: Dermal Filler Market Regions Covered, Global (2 of 2) |
| Figure 7‑5: Dermal Filler Procedures by Segment, Global, 2019 – 2029 |
| Figure 7‑6: Dermal Filler Procedures by Region, Global, 2019 – 2029 |
| Figure 7‑7: Dermal Filler Procedures by Country, North America, 2019 – 2029 |
| Figure 7‑8: Dermal Filler Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 7‑9: Dermal Filler Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 7‑10: Dermal Filler Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 7‑11: Dermal Filler Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 7‑12: Dermal Filler Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 7‑13: Dermal Filler Procedures by Country, Middle East, 2019 – 2029 |
| Figure 7‑14: Dermal Filler Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 7‑15: Dermal Filler Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 7‑16: Dermal Filler Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 7‑17: Dermal Filler Procedures by Country, Africa, 2019 – 2029 |
| Figure 7‑18: Hyaluronic Acid Dermal Filler Procedures by Region, Global, 2019 – 2029 |
| Figure 7‑19: Synthetic Dermal Filler Procedures by Region, Global, 2019 – 2029 |
| Figure 7‑20: Dermal Filler Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 7‑21: Dermal Filler Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 7‑22: Dermal Filler Market, Global, 2019 – 2029 |
| Figure 7‑23: Units Sold by Region, Dermal Filler Market, Global, 2019 – 2029 |
| Figure 7‑24: Average Selling Price by Region, Dermal Filler Market, Global, 2019 – 2029 (US$) |
| Figure 7‑25: Market Value by Region, Dermal Filler Market, Global, 2019 – 2029 (US$M) |
| Figure 7‑26: Hyaluronic Acid Dermal Filler Market, Global, 2019 – 2029 |
| Figure 7‑27: Units Sold (1cc Syringe) by Region, Hyaluronic Acid Dermal Filler Market, Global, 2019 – 2029 |
| Figure 7‑28: Average Selling Price by Region, Hyaluronic Acid Dermal Filler Market, Global, 2019 – 2029 (US$) |
| Figure 7‑29: Market Value by Region, Hyaluronic Acid Dermal Filler Market, Global, 2019 – 2029 (US$M) |
| Figure 7‑30: Synthetic Dermal Filler Market, Global, 2019 – 2029 |
| Figure 7‑31: Units Sold (1cc Syringe) by Region, Synthetic Dermal Filler Market, Global, 2019 – 2029 |
| Figure 7‑32: Average Selling Price by Region, Synthetic Dermal Filler Market, Global, 2019 – 2029 (US$) |
| Figure 7‑33: Market Value by Region, Synthetic Dermal Filler Market, Global, 2019 – 2029 (US$M) |
| Figure 7‑34: Leading Competitors, Dermal Filler Market, Global, 2022 |
| Figure 7‑35: Leading Competitors, Dermal Filler Market by Segment, Global, 2022 |
| Figure 8‑1: Breast Procedures Covered |
| Figure 8‑2: Breast Implant Markets Covered |
| Figure 8‑3: Breast Implant Market Regions Covered, Global (1 of 2) |
| Figure 8‑4: Breast Implant Market Regions Covered, Global (2 of 2) |
| Figure 8‑5: Breast Procedures by Segment, Global, 2019 – 2029 |
| Figure 8‑6: Breast Procedures by Region, Global, 2019 – 2029 |
| Figure 8‑7: Breast Procedures by Country, North America, 2019 – 2029 |
| Figure 8‑8: Breast Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 8‑9: Breast Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 8‑10: Breast Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 8‑11: Breast Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 8‑12: Breast Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 8‑13: Breast Procedures by Country, Middle East, 2019 – 2029 |
| Figure 8‑14: Breast Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 8‑15: Breast Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 8‑16: Breast Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 8‑17: Breast Procedures by Country, Africa, 2019 – 2029 |
| Figure 8‑18: Breast Augmentation Procedures by Region, Global, 2019 – 2029 |
| Figure 8‑19: Breast Implant Removal Procedures by Region, Global, 2019 – 2029 |
| Figure 8‑20: Breast Lift Procedures by Region, Global, 2019 – 2029 |
| Figure 8‑21: Breast Reduction Procedures by Region, Global, 2019 – 2029 |
| Figure 8‑22: Breast Implant Market by Material Type, Global, 2019 – 2029 (US$M) |
| Figure 8‑23: Breast Implant Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 8‑24: Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑25: Units Sold by Region, Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑26: Average Selling Price by Region, Breast Implant Market, Global, 2019 – 2029 (US$) |
| Figure 8‑27: Market Value by Region, Breast Implant Market, Global, 2019 – 2029 (US$M) |
| Figure 8‑28: Saline Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑29: Units Sold by Region, Saline Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑30: Average Selling Price by Region, Saline Breast Implant Market, Global, 2019 – 2029 (US$) |
| Figure 8‑31: Market Value by Region, Saline Breast Implant Market, Global, 2019 – 2029 (US$M) |
| Figure 8‑32: Silicone Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑33: Units Sold by Region, Silicone Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑34: Average Selling Price by Region, Silicone Breast Implant Market, Global, 2019 – 2029 (US$) |
| Figure 8‑35: Market Value by Region, Silicone Breast Implant Market, Global, 2019 – 2029 (US$M) |
| Figure 8‑36: Silicone Breast Implant Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 8‑37: Smooth Silicone Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑38: Units Sold by Region, Smooth Silicone Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑39: Average Selling Price by Region, Smooth Silicone Breast Implant Market, Global, 2019 – 2029 (US$) |
| Figure 8‑40: Market Value by Region, Smooth Silicone Breast Implant Market, Global, 2019 – 2029 (US$M) |
| Figure 8‑41: Textured Silicone Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑42: Units Sold by Region, Textured Silicone Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑43: Average Selling Price by Region, Textured Silicone Breast Implant Market, Global, 2019 – 2029 (US$) |
| Figure 8‑44: Market Value by Region, Textured Silicone Breast Implant Market, Global, 2019 – 2029 (US$M) |
| Figure 8‑45: Units Sold by Implant Shape, Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑46: Units Sold by Region, Round Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑47: Units Sold by Region, Anatomical Breast Implant Market, Global, 2019 – 2029 |
| Figure 8‑48: Leading Competitors, Breast Implant Market, Global, 2022 |
| Figure 8‑49: Leading Competitors by Segment, Breast Implant Market, Global, 2022 |
| Figure 9‑1: Facial and Body Implant Procedures Covered |
| Figure 9‑2: Facial and Body Implant Markets Covered |
| Figure 9‑3: Facial and Body Implant Market Regions Covered, Global (1 of 2) |
| Figure 9‑4: Facial and Body Implant Market Regions Covered, Global (2 of 2) |
| Figure 9‑5: Facial and Body Implant Procedures by Segment, Global, 2019 – 2029 |
| Figure 9‑6: Facial and Body Implant Procedures by Region, Global, 2019 – 2029 |
| Figure 9‑7: Facial and Body Implant Procedures by Country, North America, 2019 – 2029 |
| Figure 9‑8: Facial and Body Implant Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 9‑9: Facial and Body Implant Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 9‑10: Facial and Body Implant Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 9‑11: Facial and Body Implant Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 9‑12: Facial and Body Implant Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 9‑13: Facial and Body Implant Procedures by Country, Middle East, 2019 – 2029 |
| Figure 9‑14: Facial and Body Implant Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 9‑15: Facial and Body Implant Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 9‑16: Facial and Body Implant Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 9‑17: Facial and Body Implant Procedures by Country, Africa, 2019 – 2029 |
| Figure 9‑18: Chin Implant Removal Procedures by Region, Global, 2019 – 2029 |
| Figure 9‑19: Malar Implant Procedures by Region, Global, 2019 – 2029 |
| Figure 9‑20: Pectoral Implant Procedures by Region, Global, 2019 – 2029 |
| Figure 9‑21: Gluteal Implant Procedures by Region, Global, 2019 – 2029 |
| Figure 9‑22: Calf Implant Procedures by Region, Global, 2019 – 2029 |
| Figure 9‑23: Facial and Body Implant Market by Anatomy, Global, 2019 – 2029 (US$M) |
| Figure 9‑24: Facial and Body Implant Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 9‑25: Total Facial and Body Implant Market, Global, 2019 – 2029 |
| Figure 9‑26: Units Sold by Region, Facial and Body Implant Market, Global, 2019 – 2029 |
| Figure 9‑27: Average Selling Price by Region, Facial and Body Implant Market, Global, 2019 – 2029 (US$) |
| Figure 9‑28: Market Value by Region, Facial and Body Implant Market, Global, 2019 – 2029 (US$M) |
| Figure 9‑29: Chin Implant Market, Global, 2019 – 2029 |
| Figure 9‑30: Units Sold by Region, Chin Implant Market, Global, 2019 – 2029 |
| Figure 9‑31: Average Selling Price by Region, Chin Implant Market, Global, 2019 – 2029 (US$) |
| Figure 9‑32: Market Value by Region, Chin Implant Market, Global, 2019 – 2029 (US$M) |
| Figure 9‑33: Malar Implant Market, Global, 2019 – 2029 |
| Figure 9‑34: Units Sold by Region, Malar Implant Market, Global, 2019 – 2029 |
| Figure 9‑35: Average Selling Price by Region, Malar Implant Market, Global, 2019 – 2029 (US$) |
| Figure 9‑36: Market Value by Region, Malar Implant Market, Global, 2019 – 2029 (US$M) |
| Figure 9‑37: Pectoral Implant Market, Global, 2019 – 2029 |
| Figure 9‑38: Units Sold by Region, Pectoral Implant Market, Global, 2019 – 2029 |
| Figure 9‑39: Average Selling Price by Region, Pectoral Implant Market, Global, 2019 – 2029 (US$) |
| Figure 9‑40: Market Value by Region, Pectoral Implant Market, Global, 2019 – 2029 (US$M) |
| Figure 9‑41: Gluteal Implant Market, Global, 2019 – 2029 |
| Figure 9‑42: Units Sold by Region, Gluteal Implant Market, Global, 2019 – 2029 |
| Figure 9‑43: Average Selling Price by Region, Gluteal Implant Market, Global, 2019 – 2029 (US$) |
| Figure 9‑44: Market Value by Region, Gluteal Implant Market, Global, 2019 – 2029 (US$M) |
| Figure 9‑45: Calf Implant Market, Global, 2019 – 2029 |
| Figure 9‑46: Units Sold by Region, Calf Implant Market, Global, 2019 – 2029 |
| Figure 9‑47: Average Selling Price by Region, Calf Implant Market, Global, 2019 – 2029 (US$) |
| Figure 9‑48: Market Value by Region, Calf Implant Market, Global, 2019 – 2029 (US$M) |
| Figure 9‑49: Leading Competitors, Facial and Body Implant Market, Global, 2022 |
| Figure 10‑1: Liposuction Device Markets Covered |
| Figure 10‑2: Liposuction Device Market Regions Covered, Global (1 of 2) |
| Figure 10‑3: Liposuction Device Market Regions Covered, Global (2 of 2) |
| Figure 10‑4: Liposuction Procedures by Region, Global, 2019 – 2029 |
| Figure 10‑5: Liposuction Procedures by Country, North America, 2019 – 2029 |
| Figure 10‑6: Liposuction Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 10‑7: Liposuction Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 10‑8: Liposuction Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 10‑9: Liposuction Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 10‑10: Liposuction Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 10‑11: Liposuction Procedures by Country, Middle East, 2019 – 2029 |
| Figure 10‑12: Liposuction Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 10‑13: Liposuction Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 10‑14: Liposuction Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 10‑15: Liposuction Procedures by Country, Africa, 2019 – 2029 |
| Figure 10‑16: Liposuction Device Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 10‑17: Liposuction Device Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 10‑18: Liposuction Tubing Market, Global, 2019 – 2029 |
| Figure 10‑19: Units Sold by Region, Liposuction Tubing Market, Global, 2019 – 2029 |
| Figure 10‑20: Average Selling Price by Region, Liposuction Tubing Market, Global, 2019 – 2029 (US$) |
| Figure 10‑21: Market Value by Region, Liposuction Tubing Market, Global, 2019 – 2029 (US$M) |
| Figure 10‑22: Liposuction Cannula Market, Global, 2019 – 2029 |
| Figure 10‑23: Units Sold by Region, Liposuction Cannula Market, Global, 2019 – 2029 |
| Figure 10‑24: Average Selling Price by Region, Liposuction Cannula Market, Global, 2019 – 2029 (US$) |
| Figure 10‑25: Market Value by Region, Liposuction Cannula Market, Global, 2019 – 2029 (US$M) |
| Figure 10‑26: Liposuction Aspiration Unit Market, Global, 2019 – 2029 |
| Figure 10‑27: Units Sold by Region, Liposuction Aspiration Unit Market, Global, 2019 – 2029 |
| Figure 10‑28: Average Selling Price by Region, Liposuction Aspiration Unit Market, Global, 2019 – 2029 (US$) |
| Figure 10‑29: Market Value by Region, Liposuction Aspiration Unit Market, Global, 2019 – 2029 (US$M) |
| Figure 10‑30: Leading Competitors, Liposuction Device Market, Global, 2022 |
| Figure 11‑1: Minimally Invasive Fat Reduction Procedures Covered |
| Figure 11‑2: Minimally Invasive Fat Reduction Device Markets Covered |
| Figure 11‑3: Minimally Invasive Fat Reduction Device Market Regions Covered, Global (1 of 2) |
| Figure 11‑4: Minimally Invasive Fat Reduction Device Market Regions Covered, Global (2 of 2) |
| Figure 11‑5: Minimally Invasive Fat Reduction Procedures by Segment, Global, 2019 – 2029 |
| Figure 11‑6: Minimally Invasive Fat Reduction Procedures by Region, Global, 2019 – 2029 |
| Figure 11‑7: Minimally Invasive Fat Reduction Procedures by Country, North America, 2019 – 2029 |
| Figure 11‑8: Minimally Invasive Fat Reduction Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 11‑9: Minimally Invasive Fat Reduction Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 11‑10: Minimally Invasive Fat Reduction Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 11‑11: Minimally Invasive Fat Reduction Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 11‑12: Minimally Invasive Fat Reduction Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 11‑13: Minimally Invasive Fat Reduction Procedures by Country, Middle East, 2019 – 2029 |
| Figure 11‑14: Minimally Invasive Fat Reduction Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 11‑15: Minimally Invasive Fat Reduction Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 11‑16: Minimally Invasive Fat Reduction Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 11‑17: Minimally Invasive Fat Reduction Procedures by Country, Africa, 2019 – 2029 |
| Figure 11‑18: Kybella® Injection Procedures by Region, Global, 2019 – 2029 |
| Figure 11‑19: Non-Injectable Fat Reduction Procedures by Region, Global, 2019 – 2029 |
| Figure 11‑20: Minimally Invasive Fat Reduction Device Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 11‑21: Minimally Invasive Fat Reduction Device Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 11‑22: Cryolipolysis Fat Reduction Device Market, Global, 2019 – 2029 |
| Figure 11‑23: Units Sold by Region, Cryolipolysis Fat Reduction Device Market, Global, 2019 – 2029 |
| Figure 11‑24: Average Selling Price by Region, Cryolipolysis Fat Reduction Device Market, Global, 2019 – 2029 (US$) |
| Figure 11‑25: Market Value by Region, Cryolipolysis Fat Reduction Device Market, Global, 2019 – 2029 (US$M) |
| Figure 11‑26: Ultrasound Lipolysis Device Market, Global, 2019 – 2029 |
| Figure 11‑27: Units Sold by Region, Ultrasound Lipolysis Device Market, Global, 2019 – 2029 |
| Figure 11‑28: Average Selling Price by Region, Ultrasound Lipolysis Device Market, Global, 2019 – 2029 (US$) |
| Figure 11‑29: Market Value by Region, Ultrasound Lipolysis Device Market, Global, 2019 – 2029 (US$M) |
| Figure 11‑30: Laser Lipolysis Device Market, Global, 2019 – 2029 |
| Figure 11‑31: Units Sold by Region, Laser Lipolysis Device Market, Global, 2019 – 2029 |
| Figure 11‑32: Average Selling Price by Region, Laser Lipolysis Device Market, Global, 2019 – 2029 (US$) |
| Figure 11‑33: Market Value by Region, Laser Lipolysis Device Market, Global, 2019 – 2029 (US$M) |
| Figure 11‑34: Kybella® Injection Market, Global, 2019 – 2029 |
| Figure 11‑35: Units Sold by Region, Kybella® injection Market, Global, 2019 – 2029 |
| Figure 11‑36: Average Selling Price by Region, Kybella® injection Market, Global, 2019 – 2029 (US$) |
| Figure 11‑37: Market Value by Region, Kybella® injection Market, Global, 2019 – 2029 (US$M) |
| Figure 11‑38: Leading Competitors, Minimally Invasive Fat Reduction Device Market, Global, 2022 |
| Figure 11‑39: Leading Competitors, Minimally Invasive Fat Reduction Device Market by Segment, Global, 2022 |
| Figure 12‑1: Aesthetic Laser and Light Procedures Covered |
| Figure 12‑2: Aesthetic Laser and Light Therapy Markets Covered |
| Figure 12‑3: Aesthetic Laser and Light Therapy Market Regions Covered, Global (1 of 2) |
| Figure 12‑4: Aesthetic Laser and Light Therapy Market Regions Covered, Global (2 of 2) |
| Figure 12‑5: Skin-Based Procedures by Segment, Global, 2019 – 2029 |
| Figure 12‑6: Aesthetic Laser and Light Procedures by Region, Global, 2019 – 2029 |
| Figure 12‑7: Aesthetic Laser and Light Procedures by Country, North America, 2019 – 2029 |
| Figure 12‑8: Aesthetic Laser and Light Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 12‑9: Aesthetic Laser and Light Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 12‑10: Aesthetic Laser and Light Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 12‑11: Aesthetic Laser and Light Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 12‑12: Aesthetic Laser and Light Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 12‑13: Aesthetic Laser and Light Procedures by Country, Middle East, 2019 – 2029 |
| Figure 12‑14: Aesthetic Laser and Light Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 12‑15: Aesthetic Laser and Light Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 12‑16: Aesthetic Laser and Light Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 12‑17: Aesthetic Laser and Light Procedures by Country, Africa, 2019 – 2029 |
| Figure 12‑18: Skin Tightening Procedures by Region, Global, 2019 – 2029 |
| Figure 12‑19: Laser Skin Resurfacing Procedures by Region, Global, 2019 – 2029 |
| Figure 12‑20: Microdermabrasion Procedures by Region, Global, 2019 – 2029 |
| Figure 12‑21: Intense Pulsed Light Procedures by Region, Global, 2019 – 2029 |
| Figure 12‑22: Laser Hair Removal Procedures by Region, Global, 2019 – 2029 |
| Figure 12‑23: Aesthetic Laser and Light Therapy Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 12‑24: Aesthetic Laser and Light Therapy Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 12‑25: Aesthetic Laser and Light Therapy Market, Global, 2019 – 2029 |
| Figure 12‑26: Units Sold by Region, Aesthetic Laser and Light Therapy Market, Global, 2019 – 2029 |
| Figure 12‑27: Average Selling Price by Region, Aesthetic Laser and Light Therapy Market, Global, 2019 – 2029 (US$) |
| Figure 12‑28: Market Value by Region, Aesthetic Laser and Light Therapy Market, Global, 2019 – 2029 (US$M) |
| Figure 12‑29: Intense Pulsed Light System Market, Global, 2019 – 2029 |
| Figure 12‑30: Units Sold by Region, Intense Pulsed Light System Market, Global, 2019 – 2029 |
| Figure 12‑31: Average Selling Price by Region, Intense Pulsed Light System Market, Global, 2019 – 2029 (US$) |
| Figure 12‑32: Market Value by Region, Intense Pulsed Light System Market, Global, 2019 – 2029 (US$M) |
| Figure 12‑33: Fractional Laser Market, Global, 2019 – 2029 |
| Figure 12‑34: Units Sold by Region, Fractional Laser Market, Global, 2019 – 2029 |
| Figure 12‑35: Average Selling Price by Region, Fractional Laser Market, Global, 2019 – 2029 (US$) |
| Figure 12‑36: Market Value by Region, Fractional Laser Market, Global, 2019 – 2029 (US$M) |
| Figure 12‑37: RF Skin Tightening Market, Global, 2019 – 2029 |
| Figure 12‑38: Units Sold by Region, RF Skin Tightening Market, Global, 2019 – 2029 |
| Figure 12‑39: Average Selling Price by Region, RF Skin Tightening Market, Global, 2019 – 2029 (US$) |
| Figure 12‑40: Market Value by Region, RF Skin Tightening Market, Global, 2019 – 2029 (US$M) |
| Figure 12‑41: Diode Laser Market, Global, 2019 – 2029 |
| Figure 12‑42: Units Sold by Region, Diode Laser Market, Global, 2019 – 2029 |
| Figure 12‑43: Average Selling Price by Region, Diode Laser Market, Global, 2019 – 2029 (US$) |
| Figure 12‑44: Market Value by Region, Diode Laser Market, Global, 2019 – 2029 (US$M) |
| Figure 12‑45: Tattoo Removal Device Market, Global, 2019 – 2029 |
| Figure 12‑46: Units Sold by Region, Tattoo Removal Device Market, Global, 2019 – 2029 |
| Figure 12‑47: Average Selling Price by Region, Tattoo Removal Device Market, Global, 2019 – 2029 (US$) |
| Figure 12‑48: Market Value by Region, Tattoo Removal Device Market, Global, 2019 – 2029 (US$M) |
| Figure 12‑49: Leading Competitors, Aesthetic Laser and Light Therapy Market, Global, 2022 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Click Here to Read More About Our Methodology
